Q4 2019 Torrent Pharmaceuticals Ltd Earnings Call Transcript
Good evening, ladies and gentlemen, and welcome to Q4 FY '19 earnings call of Torrent Pharmaceuticals Limited.
We have with us, Sri Sanjay Gupta, Executive Director, International Business; Sri Dhruv Gulati, Executive Director India and ROW Business; and Sri Sudhir Menon, CFO, who will represent Torrent Pharmaceuticals on the call.
(Operator Instructions)
Please note that this conference is being recorded.
I now hand the conference over to Sri Sanjay Gupta for opening remarks. Thank you, and over to you, sir.
Thank you, and good evening, everyone, and welcome to the financial year '19 conference call.
I will start with the Q4 results. Q4 revenues were up by 9% at INR 1,856 crores. Q4 EBITDA margin before exceptional items was at 26%. For the full fiscal year, revenues were at INR 7,673 crores with a year-on-year growth of 29%. The Board of Torrent Pharma has recommended a final dividend of INR 54 per equity share.
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
